| |
 |
|
Our team / Postdoctoral Fellows
 |
|
Sophie Kulaga, MSc, PhD
Year : 2008 - 2009
Dr. Kulaga is an epidemiologist who has recently joined Dr. Anick Bérard's research team as a postdoctoral fellow. She holds a bachelor's degree in Biology and in Communication Studies. Dr. Kulaga received her master's degree and PhD from the Department of Epidemiology, Biostatistics and Occupational Health at the Faculty of Medicine of McGill University.
Research topic
Teratogen drugs use during pregnancy in the province of Quebec.
|

|
 |
|
Hamid Reza Nakhai-Pour, MD, MSc, PhD
Year : 2007 - 2009
Dr. Nakhai-Pour received his M.D., his master's degree in Clinical epidemiology, and his Doctor of Science in Clinical epidemiology at the Netherlands Institute of Health Sciences in the Netherlands. Afterwards, he completed his PhD in Clinical epidemiology at the Julius Center of Health Sciences and Primary Care at the University of Utrecht in the Netherlands. Dr. Nakhai-Pour's primary research interests have been in the fields of cardiovascular clinical epidemiology, cardiovascular pharmacoepidemiology, and evidence-based medicine. Following this, he trained as a teacher at Oxford Centre for Evidence-Based Medicine Department of Public Health at the University of Oxford in England. Recently, Dr. Nakhai-Pour joined Dr. Anick Bérard's research team for a postdoctoral fellowship in pharmacoepidemiology.
Research topic
Antihypertensive drugs use during pregnancy: Risks and benefits for the mother and child.
» Read this topic
|

|
 |
|
Benjamin Ofori, BPharm, MSc, PhD
Year : 2005 - 2007
Dr. Ofori holds a bachelor's degree with honours in Pharmacy from the University of Bath in England, a master's degree in clinical pharmacy, and a certificate in Health Economics from the University of Aberdeen in Scotland. He also holds a PhD in Pharmaceutical sciences from the University of Dundee in Scotland. In 2005, he moved to Canada and joined Dr. Bérard's research team for a postdoctoral fellowship at CHU Sainte-Justine. He then moved to work for Amgen Canada Inc.
Research topic
Medications in Pregnancy: Risks of premature birth, congenital malformations, and healthcare costs.
» Read this topic
|
|
|
 |
|